Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Advil Dual Action with Acetaminophen** is an oral fixed-dose, over-the-counter analgesic product containing acetaminophen 250 mg and ibuprofen 125 mg per caplet. Ibuprofen is a nonselective cyclooxygenase inhibitor that reduces peripheral prostaglandin synthesis, while acetaminophen provides centrally mediated analgesia through mechanisms that are not fully resolved. The Haleon product is used for temporary relief of minor pain, including headache, toothache, backache, menstrual cramps, muscular aches, and minor arthritis pain. ([advil.com](https://www.advil.com/our-products/advil-pain/advil-dual-action/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + ibuprofen (Pfizer).